Literature DB >> 1563812

Introduction of hepatitis delta virus into Polish drug community.

T Laskus1, M Radkowski, E Lupa, J Cianciara, J Slusarczyk, G Halama, A Horban.   

Abstract

The prevalence of hepatitis delta virus (HDV) infection was studied in 140 unselected intravenous drug addicts whose sera were drawn between 1985 and 1986 and in 100 addicts from whom sera were obtained between 1988 and 1989. It was observed that 1.8% of those positive for hepatitis B virus (HBV) markers from the earlier period and 23.2% of those from the later period had detectable anti-delta antibodies. Among drug addicts referred with acute or chronic HBV infection, the first evidence of HDV infection was found in 1986. We conclude that HDV infection was introduced into the Warsaw drug community in the mid 1980s.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563812     DOI: 10.1007/bf01704895

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

1.  Infection with delta agent in Sweden: introduction of a new hepatitis agent.

Authors:  B G Hansson; T Moestrup; A Widell; E Nordenfelt
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

2.  Hepatitis delta virus infections in intravenous drug abusers with hepatitis B in the west of Scotland.

Authors:  E A McCruden; E A Follett
Journal:  J Med Virol       Date:  1989-09       Impact factor: 2.327

3.  Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.

Authors:  G Raimondo; A Smedile; L Gallo; A Balbo; A Ponzetto; M Rizzetto
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

4.  Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus.

Authors:  A Ponzetto; L B Seeff; Z Buskell-Bales; K G Ishak; J H Hoofnagle; H J Zimmerman; R H Purcell; J L Gerin
Journal:  Hepatology       Date:  1984 Nov-Dec       Impact factor: 17.425

5.  Acute non-A, non-B hepatitis in a hospital population in Warsaw, Poland: clinical and epidemiological aspects.

Authors:  T Laskus; E Lupa; J Cianciara; J Slusarczyk
Journal:  Am J Gastroenterol       Date:  1991-05       Impact factor: 10.864

6.  Hepatitis B infection in the United States. Recent trends and future strategies for control.

Authors:  M A Kane; M J Alter; S C Hadler; H S Margolis
Journal:  Am J Med       Date:  1989-09-04       Impact factor: 4.965

7.  Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections.

Authors:  A G Shattock; F M Irwin; B M Morgan; I B Hillary; M G Kelly; J F Fielding; D A Kelly; D G Weir
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

8.  Acute type A, B, and non-A, non-B hepatitis in a hospital population in London: clinical and epidemiological features.

Authors:  M Bamber; H C Thomas; B Bannister; S Sherlock
Journal:  Gut       Date:  1983-06       Impact factor: 23.059

  8 in total
  2 in total

Review 1.  Hepatitis viruses: changing patterns of human disease.

Authors:  R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

2.  Hepatitis D, B and C virus (HDV/HBV/HCV) coinfection as a diagnostic problem and therapeutic challenge.

Authors:  Beata Lorenc; Katarzyna Sikorska; Piotr Stalke; Krzysztof Bielawski; Dominik Ziętkowski
Journal:  Clin Exp Hepatol       Date:  2017-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.